Butterfly NetworkFRA:7JA +1.63%40 FCF Margin % is -55.95% as of Mar. 2026. GuruFocus rates FRA:7JA with a GF Score™ of 40/100 and a GF Value™ of €2.00 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Butterfly Network ranks worse than 70.59% on this metric.
The historical rank and industry rank for Butterfly Network's FCF Margin % or its related term are showing as below:
FRA:7JA'
s FCF Margin % Range Over the Past 10 Years
Min: -452.82 Med: -181.78 Max: -16.44
Current: -18.51
During the past 7 years, the highest FCF Margin % of Butterfly Network was -16.44%. The lowest was -452.82%. And the median was -181.78%.
FRA:7JA's FCF Margin % is ranked worse than 70.59% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: -0.375
vs FRA:7JA: -18.51
Butterfly Network FCF Margin % Related Terms
Butterfly Network FCF Margin % Historical Data
* Premium members only.
The historical data trend for Butterfly Network's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:7JA vs TMDX, AXGN, NEOG: FCF Margin % Comparison
For the Medical Devices subindustry, Butterfly Network's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Butterfly Network FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Butterfly Network's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Butterfly Network's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Butterfly Network (FRA:7JA) has a FCF Margin % of -55.95% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Butterfly Network and its competitors. According to the industry distribution chart, Butterfly Network ranks #576 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 70.6%.
Is Butterfly Network's FCF Margin % too high?
Butterfly Network's current FCF Margin % is -55.95%. Based on the distribution chart, Butterfly Network ranks #576 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Butterfly Network has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Butterfly Network's FCF Margin % compare to TMDX and AXGN?
According to the Medical Devices & Instruments industry distribution chart, Butterfly Network ranks #576 out of 816 companies for FCF Margin %. This places Butterfly Network in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Butterfly Network and its competitors. Butterfly Network's current FCF Margin % is -55.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Butterfly Network stock overvalued right now?
Based on GuruFocus' analysis, Butterfly Network (FRA:7JA) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.00, compared to a current price of €7.18 — trading 259% above its estimated fair value. The current FCF Margin % is -55.95%. Butterfly Network's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Butterfly Network (FRA:7JA), the current FCF Margin % is -55.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Butterfly Network (FRA:7JA) Overvalued in 2026?
Based on GuruFocus' analysis, Butterfly Network stock appears to be overvalued.
The current stock price of €7.18 is trading 259% above its estimated GF Value™ of €2.00.
GuruFocus considers Butterfly Network to be Significantly Overvalued.
Key valuation signals for FRA:7JA:
FCF Margin %: -55.95%
GF Value™: €2.00 vs. price of €7.18 (259% above fair value)
No single metric tells the full story. See the FRA:7JA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.
40GF Score
Get the complete analysis for FRA:7JA
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7JA has been successfully added to your 
